Caliway Biopharmaceuticals' novel injectable drug shows promise for millions

Caliway Biopharmaceuticals has developed an injectable therapy that acts via a novel mechanism, potentially offering relief to millions. The claim is based on promotional material and lacks clinical data or regulatory milestones. If approved, it could represent a significant therapeutic advance, but efficacy and safety remain unverified.

AI disclosure: Model-written summary of the source, not a verified fact. Check the sources. How Mosaic works